TNFSF10 and hydrops fetalis: A statistically significant difference (p<0.001) was observed in terms of number of adverse outcomes in the follow-up, suggesting that the low serum levels of TRAIL measured at discharge after AMI represent a determinant of mortality and HF at 12 months of follow-up in this study population.